Kiromic Biopharma Inc. (KRBP): Price and Financial Metrics
KRBP Price/Volume Stats
| Current price | $2.71 | 52-week high | $8.97 |
| Prev. close | $2.64 | 52-week low | $0.16 |
| Day low | $2.64 | Volume | 1,500 |
| Day high | $2.95 | Avg. volume | 8,272 |
| 50-day MA | $2.65 | Dividend yield | N/A |
| 200-day MA | $1.64 | Market Cap | 3.49M |
KRBP Stock Price Chart Interactive Chart >
Kiromic Biopharma Inc. (KRBP) Company Bio
Kiromic Biopharma, Inc. operates as a biotechnology company, which engages in the development of cancer engineered immunotherapies. Its technologies include Intelligent Immunotherapy, Diamond AI, CancerSplice, ABBIE, and CAR-T Proprietary Binder Technology. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX.
Latest KRBP News From Around the Web
Below are the latest news stories about KIROMIC BIOPHARMA INC that investors may wish to consider to help them evaluate KRBP as an investment opportunity.
Kiromic BioPharma Welcomes Two New Directors to its BoardHOUSTON, July 24, 2023--Kiromic BioPharma, Inc. (NASDAQ: KRBP) ("Kiromic" or the "Company"), a clinical-stage, fully-integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence and data mining platform to develop cell therapies with a focus on immuno-oncology, announces the appointments of Pamela Misajon and Michael Catlin to its Board of Directors. Their regulatory and finance experience enhances Kiromic’s governance and re-establishes the Company’s five-member Boa |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayWe're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday! |
What's Going On With Kiromic BioPharma Stock WednesdayKiromic BioPharma Inc (NASDAQ: KRBP) shares are gaining Wednesday morning. However, there is no specific news today. During the session, the share price reached $9.22. Monday morning, the FDA authorized the company's Investigational New Drug (IND) application to initiate a Phase 1 trial to evaluate Deltacel (KB-GDT-01) for patients with non-small cell lung cancer (NSCLC). The company expects to start the trial in Q2 of 2023. Deltacel is the company's allogeneic, non-engineered, off-the-shelf Gam |
Kiromic BioPharma Announces FDA Authorization of IND to Initiate Phase 1 Clinical Trial Evaluating Deltacel in Non-Small Cell Lung CancerHOUSTON, May 01, 2023--Kiromic BioPharma Announces FDA Authorization of IND to Initiate Phase 1 Clinical Trial Evaluating Deltacel in Non-Small Cell Lung Cancer |
KRBP Price Returns
| 1-mo | -2.17% |
| 3-mo | 80.67% |
| 6-mo | 1,077.75% |
| 1-year | -35.28% |
| 3-year | -98.92% |
| 5-year | N/A |
| YTD | 211.49% |
| 2023 | -83.95% |
| 2022 | -88.19% |
| 2021 | -81.94% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...